As of August 28, 2026, NervGen Pharma Corp. (NGEN) has a DilutionWatch DilutionScore of 35/100, rated MEDIUM dilution risk. NervGen Pharma Corp. has a market capitalization of $219.84M, 79.65M shares outstanding, 44 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for NGEN.
Market Data
Market Cap$219.84M
Shares Outstanding79.65M
Float68.03M
Cash$12.00M
DebtN/A
Short InterestN/A
Institutional Holdings
44 institutional holders · 1.68M shares
#1
PFG Investments, LLC
201.0K shares
#2
BANK OF AMERICA CORP /DE/
200.7K shares
#3
MARSHALL WACE, LLP
200.4K shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest5.44M
Days to Cover9.8
% of Float8.0%
FINRA data as of Jul 31, 2026
Recent SEC Activity
No recent SEC insights
Recent News
No recent news
Track NGEN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NGEN — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for NGEN
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.